Rapid Learning for Lung Cancer
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01949259|
Recruitment Status : Completed
First Posted : September 24, 2013
Last Update Posted : September 30, 2016
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||10000 participants|
|Official Title:||Rapid Learning in Practice: A Lung Cancer Survival Decision Support System in Routine Patient Care Data|
|Study Start Date :||September 2013|
|Actual Primary Completion Date :||August 2014|
|Actual Study Completion Date :||August 2014|
Retrospective collection of data from included lung cancer patients.
- Survival [ Time Frame: From radiotherapy until death ]Retrospective data will be collected from each included patient from start of radiotherapy until end of study or death (an expected average of 10 years).
- Local control [ Time Frame: From start of treatment until death, ]Data will be collected from inclusion in the study until end of study of death (an expected average time frame of 10 years) concerning the local control of this tumour.
- Distant metastases [ Time Frame: From treatment until end of study ]Data concerning the possible occurence of distant metastases will be collected from each patient from inclusion until end of study or date of death (an expected average time frame of 10 years).
- Dyspnea [ Time Frame: From inclusion until end of study ]From each included patient, dyspnea scores will be collected from start of treatment until end of study or date of death (an expected average time frame of 10 years).
- Dysphagia [ Time Frame: From treatment until end of study ]Dysphagia scores will be collected from each participating patient from treatment until end of study or date of death (an average time frame of 10 years)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||Child, Adult, Older Adult|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||No|
|Sampling Method:||Non-Probability Sample|
- Patients notes as suffering from lung cancer in at least one clinical data source.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01949259
|Maastricht, Limburg, Netherlands, 6229 ET|
|Principal Investigator:||Andre Dekker, Dr||Maastro Clinic, The Netherlands|
|Responsible Party:||Maastricht Radiation Oncology|
|Other Study ID Numbers:||
Rapid learning lung cancer
|First Posted:||September 24, 2013 Key Record Dates|
|Last Update Posted:||September 30, 2016|
|Last Verified:||September 2016|
Respiratory Tract Neoplasms
Neoplasms by Site
Respiratory Tract Diseases